Tag: software
-
Trial Testing Ultrasound Technique to Move Kidney Stones
A clinical trial at University of Washington in Seattle is testing an ultrasound device that moves the position of kidney stones in the body to encourage safe passage of the stones without surgery. The early-stage trial is testing the device invented in the lab of engineering professor Mike Bailey, who is also starting a company…
-
DNA Diagnostics Company to Crowdfund Malaria Testing Device
QuantuMDx, a biotechnology company in Newcastle, U.K. says it will start a crowdfunding campaign next month to finance development and field trials of a handheld device to test for malaria. The device is an application of its Q-POC point-of-care diagnostics system, which will be the subject of an Indiegogo campaign beginning 12 February. The company,…
-
UCSF, Quest Diagnostics to Partner on Precision Medicine
Medical diagnostics provider Quest Diagnostics in Madison, New Jersey and University of California in San Francisco are researching new tests based on genetic and molecular indicators to better find genetic causes of developmental disorders like autism, and identify children with brain tumors who can best respond to treatments. The collaboration is the first for UCSF…
-
Diabetes App Developer Files for FDA Pre-Market Clearance
LabStyle Innovations Corp. in Caesarea, Israel, developer of a mobile and cloud-based system for diabetes management, filed for pre-market notification of its system with the U.S. Food and Drug Administration. Pre-market notification, once granted by FDA, clears medical devices for marketing in the U.S. LabStyle Innovations created the Dario system that combines a small glucose…
-
Becton Dickinson Acquires Point-of-Care Diagnostics Maker
Becton, Dickinson and Company, a medical device manufacturer in Franklin Lakes, New Jersey is buying Alverix Inc., a developer of point-of-care diagnostics equipment in San Jose, California. The purchase price is $40 million, according to a Becton Dickinson statement. Alverix designs testing equipment for physician’s offices, retail and mobile clinics, rural settings, and homes that…
-
Large Genomic Study Finds New Rheumatoid Arthritis Targets
An international consortium of 70 institutions and companies combined genome-wide analyses with current drug databases to uncover new genomic targets for rheumatoid arthritis, and identify drugs for other diseases with the potential to treat the disorder. The team led by Robert Plenge of Harvard Medical School and the Broad Institute and Yukinori Okada from the…
-
Neurotherapies Require Collaboration, Team Science, Big Data
In a briefing today on Capitol Hill, University of Pennsylvania biomedical engineer and neurologist Brian Litt outlined requirements for harnessing promising research for patients suffering from brain disorders. The briefing in Washington, D.C. was organized by the journal Science Translational Medicine and its publisher American Association for the Advancement of Science. Litt, who is on…
-
New Process Speeds 3-D Printing of Multiple Materials
Engineers at University of Southern California in Los Angeles developed a new, faster technique for three-dimensional printing of objects made with multiple materials. Industrial engineering professor Yong Chen and colleagues from USC described their process yesterday at a meeting of the engineering organization ASME in San Diego. Despite the promise and potential of 3-D printing…
-
FDA Approves Sale of High-Throughput DNA Sequencing Systems
The U.S. Food and Drug Administration yesterday cleared for marketing high-throughput sequencing systems by Illumina Inc. in San Diego to analyze a person’s DNA. In a commentary on this approval in New England Journal of Medicine, FDA director Margaret Hamburg and National Institutes of Health director Francis Collins say, “Access to these data opens the…
-
Cancer Genomics Precision-Medicine Center Opens in Boston
A group of research institutes and hospitals in Boston is opening a new lab to study the science leading to individualized cancer therapies based on the genomic make-up of a patient’s tumors. The Joint Center for Cancer Precision Medicine is a collaboration of Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Boston Children’s Hospital, and the…